InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector
09 juin 2022 07h30 HE
|
InMed Pharmaceuticals Inc.
Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoidBolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBTTHCV has been researched for a variety of potential...
Cannabis Global Finalizes Study Parameters for THC-V Animal Study on Diet-Induced Obese (DIO) Mice
30 juil. 2020 07h30 HE
|
MCTC Holdings Inc. (d/b/a Cannabis Global)
LOS ANGELES, July 30, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- MCTC Holdings, Inc. (OTC:MCTC), dba Cannabis Global Inc., a cannabinoid and hemp extract science forward company developing infusion...